Phospholipid, arachidonate and eicosanoid signaling in schizophrenia
This paper reviews the potential role of arachidonic acid in the pathophysiology of schizophrenia.We discuss how abnormal levels of arachidonic acid may arise, and how dysregulation of signaling molecules derived from Storage it have the potential to disrupt not only dopamine signaling, but numerous other physiological processes associated with the